Team:TU Delft/9 April 2010 content

From 2010.igem.org

(Difference between revisions)
(Session 6)
 
(3 intermediate revisions not shown)
Line 1: Line 1:
-
==Session 6==
+
=Session 6=
During the meeting 9 presentations were given on different possible subjects, and following the presentations the team voted on whether we should continue with the idea or not. These were the subjects, and the outcome of the vote:
During the meeting 9 presentations were given on different possible subjects, and following the presentations the team voted on whether we should continue with the idea or not. These were the subjects, and the outcome of the vote:
Line 44: Line 44:
- Bacterial Eye
- Bacterial Eye
 +
 +
[[Image:TUDelft_Brainstorm.jpg|350px|thumb|Presentation by Pieter]]
 +
 +
==Hugo's Risk Scale==
 +
We used the Hugo Risk Scale (HRS) to determine whether an idea was feasible or not.
 +
 +
Risk is represented with a value from 0 (no risk) to 10 (very risky)
 +
# Lac operon (or other piece of cake) + our biobrick
 +
# Less than 5 genes or biobricks (copy-paste) + our biobrick
 +
# Less than 10 genes or biobricks (copy-paste) + our biobrick
 +
# Biobrick engineering <5, improvement of things already done
 +
# Multi biobrick engineering >5, improvement of things already done
 +
# Site directed mutagenesis of several genes, results unknown a priori
 +
# Evolutionary engineering involved = sequencing
 +
# Protein engineering involved, results unknown a priori
 +
# A lot of genes and/or biobricks (>20), known genes in other species and characterized. Stress, social friction
 +
# A lot of genes and/or biobricks (>20), Known genes in other species, not fully characterized. Start a project one-eyed = stress, social friction, high chances of collapse
 +
# A lot of genes (>20), Unknown genes= characterization + sequencing + cloning. Start a project from nothing or partially blind, team-member losses + obituraries. Good side: paper in Nature or Nobel

Latest revision as of 13:13, 27 October 2010

Session 6

During the meeting 9 presentations were given on different possible subjects, and following the presentations the team voted on whether we should continue with the idea or not. These were the subjects, and the outcome of the vote:

    - Exhaled breath analysis
         Vote: Yes (6/8)
    - Soil Sampling
         Vote: No (2/8)
    - Mosquito’s/Parasites
         Vote: No (0/8)
    - Cell shrinkage
         Vote: No (2/8)
    - Oil remediation (Hydrocarbon biodegradation)
         Vote: Yes (8/8)
    - Bacterial buffer
         Vote: No
    - Rainbow pH sensor
         Vote: Yes (8/8)
    - Ice melting
         Vote: No (0/8)
    - Biofilms (Linked to cell density measurement?)
         Vote: Part of another project
    - Bacterial eye
         Vote: Yes (7/8)
    - GMOs in the Gut
         Something to add to another idea

Chosen Ideas:

- Colon cancer detection

- Oil remotion

- Rainbow pH Sensor

- Bacterial Eye

Presentation by Pieter

Hugo's Risk Scale

We used the Hugo Risk Scale (HRS) to determine whether an idea was feasible or not.

Risk is represented with a value from 0 (no risk) to 10 (very risky)

  1. Lac operon (or other piece of cake) + our biobrick
  2. Less than 5 genes or biobricks (copy-paste) + our biobrick
  3. Less than 10 genes or biobricks (copy-paste) + our biobrick
  4. Biobrick engineering <5, improvement of things already done
  5. Multi biobrick engineering >5, improvement of things already done
  6. Site directed mutagenesis of several genes, results unknown a priori
  7. Evolutionary engineering involved = sequencing
  8. Protein engineering involved, results unknown a priori
  9. A lot of genes and/or biobricks (>20), known genes in other species and characterized. Stress, social friction
  10. A lot of genes and/or biobricks (>20), Known genes in other species, not fully characterized. Start a project one-eyed = stress, social friction, high chances of collapse
  11. A lot of genes (>20), Unknown genes= characterization + sequencing + cloning. Start a project from nothing or partially blind, team-member losses + obituraries. Good side: paper in Nature or Nobel